Richard Rosen, MD, Vice Chair of the Department of Ophthalmology at New York Eye and Ear Infirmary, and a team of researchers in the Shelley and Steven Einhorn Clinical Research Center, are pioneering an imaging technology that enables them to see microscopic details of the retina and its finest blood vessels at a level not previously possible in patients with sight–threatening disease.
With considerable fanfare, the Nursing staff at The Mount Sinai Hospital debuted new uniforms in Guggenheim Pavilion on Tuesday, December 10, marking the first time in more than 30 years that the entire nursing patient-care team will be identifiable by the color of their uniforms.
The Icahn School of Medicine at Mount Sinai, and National Jewish Health, the nation’s leading respiratory hospital, based in Denver, Colorado, have created a partnership to advance patient care and research in respiratory and related diseases. The Mount Sinai–National Jewish Health Respiratory Institute is expected to open on the Icahn School of Medicine campus in July.
The Mount Sinai Health System recently established the Mount Sinai Institute of Technology (MSIT), with a $5 million grant from the New York City Economic Development Corporation (NYCEDC). As part of Icahn School of Medicine at Mount Sinai, MSIT will train students to develop technology-based solutions that improve human health, and serve as an incubator for transformative, cost-effective discoveries.
In recognition of Diabetes Awareness Month in November, the Mount Sinai Diabetes Center hosted an educational event for patients, staff, and the community in the Guggenheim Atrium on how to prevent and control diabetes. It included “Viva Fitness” demonstrations and tastings by the Food and Nutrition Department.
There are more than 23 million people in the United States, including 1.6 million in New York State, who have type 2 diabetes, which occurs when the body is resistant to the action of insulin, a hormone produced by the pancreas to lower the blood sugar. Type 2 diabetes, which is often associated with obesity, can result in kidney failure, limb amputations, blindness, heart disease, and stroke when blood sugar levels are uncontrolled.
“Many of these individuals who are living with type 2 diabetes and obesity are trying tirelessly to manage their diabetes and blood sugar, but without success,” says Aida Saliby, MD, of the Department of Endocrinology at Beth Israel Medical Center. “They do not respond fully to diet and lifestyle modifications, or they become resistant to the effects of oral medications, requiring additional treatments to manage their disease. Given the severe and growing diabetes epidemic, there is a substantial need to develop new, more effective therapies,” she says.